Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia...

FinVolution Group Announces New Share Repurchase Program Up To US$150 million

FinVolution Group Announces New Share Repurchase Program Up To US$150 million

SHANGHAI, March 18, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform in China, Indonesia and the Philippines, today announced that the board of directors of the Company (the "Board")...

TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025

TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025

TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening TaiMed Biologics will reshape HIV treatment management and seeks strategic collaborations with global pharmaceutical partners for the...

Health In Tech Announces Fourth Quarter and Full Year 2024 Financial Results

Health In Tech Announces Fourth Quarter and Full Year 2024 Financial Results

Total audited revenue for 2024 was $19.5 million. The first two months of 2025, our unaudited revenue is about $5.7million, more than 50% growth year over year for the first two months of 2024, and exceeded the revenue of the entire Q1 of 2024 Cash...

GLOWMODE PARTNERS WITH NATURE DREAM BALI IN AN EXCLUSIVE ACTIVEWEAR COLLECTION DESIGNED TO "GO GLOW"

GLOWMODE PARTNERS WITH NATURE DREAM BALI IN AN EXCLUSIVE ACTIVEWEAR COLLECTION DESIGNED TO "GO GLOW"

Glowmode and Nature Dream Bali Come Together to Create a Nature-Inspired Collection with Female Empowerment and Mindfulness in Mind LOS ANGELES, March 17, 2025 /PRNewswire/ -- Glowmode, a leader in high-performance, stylish, and affordable...

Relativity Announces its Fourth Annual AI Visionaries List

Relativity Announces its Fourth Annual AI Visionaries List

The list features leaders who have played pivotal roles in AI adoption CHICAGO, March 17, 2025 /PRNewswire/ -- Relativity, a global legal technology company, today announced its fourth annual list of AI Visionaries. The list recognizes and...

BEYOND EXPO 2025 EXPANDS GLOBAL INFLUENCE WITH GROUNDBREAKING PARTNERSHIP WITH ASIAN FAMILY LEGACY FOUNDATION AND GREENWICH ECONOMIC FORUM

BEYOND EXPO 2025 EXPANDS GLOBAL INFLUENCE WITH GROUNDBREAKING PARTNERSHIP WITH ASIAN FAMILY LEGACY FOUNDATION AND GREENWICH ECONOMIC FORUM

Strengthening Asia's Position in the Global Wealth and Investment Landscape MACAO, March 17, 2025 /PRNewswire/ -- BEYOND Expo, Asia 's premier platform for technology and innovation, is proud to announce the BEYOND Wealth Summit 2025, co-hosted with...

Leptage: Pioneering the Future of Crypto Trading and Innovation

Leptage: Pioneering the Future of Crypto Trading and Innovation

WARSAW, Poland, March 17, 2025 /PRNewswire/ -- Leptage, a modern fintech platform engineered for global ambitions, proudly announces its blockchain-powered liquidity provisioning through PayFi technology to integrate multi-layered financial services...

HanAll Biopharma Announces Orphan Drug Designation for Batoclimab in Japan for Active Thyroid Eye Disease

HanAll Biopharma Announces Orphan Drug Designation for Batoclimab in Japan for Active Thyroid Eye Disease

Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). Batoclimab, subcutaneous formulation, offers the potential for at-home administration, improving patient convenience and accessibility....

Tuniu Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results and Cash Dividend

Tuniu Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results and Cash Dividend

NANJING, China, March 14, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced its unaudited financial results for the fourth quarter and fiscal year...

  • 1
  • ...
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • ...
  • 152
  • menu
    menu